News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,515 Results
Type
Article (40835)
Company Profile (267)
Press Release (679403)
Multimedia
Podcasts (79)
Webinars (17)
Section
Business (204635)
Career Advice (2022)
Deals (35530)
Drug Delivery (110)
Drug Development (81358)
Employer Resources (173)
FDA (16396)
Job Trends (14939)
News (346311)
Policy (32717)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2563)
Accelerated approval (31)
Adcomms (24)
Allergies (135)
Alliances (49574)
ALS (167)
Alzheimer's disease (1648)
Antibody-drug conjugate (ADC) (301)
Approvals (16656)
Artificial intelligence (494)
Autoimmune disease (138)
Automation (35)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (184)
Biotechnology (174)
Bladder cancer (155)
Brain cancer (55)
Breast cancer (623)
Cancer (4693)
Cardiovascular disease (390)
Career advice (1705)
Career pathing (35)
CAR-T (271)
CDC (44)
Celiac Disease (1)
Cell therapy (716)
Cervical cancer (35)
Clinical research (69411)
Collaboration (1639)
Company closure (4)
Compensation (1114)
Complete response letters (50)
COVID-19 (2706)
CRISPR (87)
C-suite (789)
Cystic fibrosis (142)
Data (6070)
Decentralized trials (2)
Denatured (25)
Depression (128)
Diabetes (490)
Diagnostics (6652)
Digital health (43)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (240)
Drug pricing (180)
Drug shortages (28)
Duchenne muscular dystrophy (223)
Earnings (89952)
Editorial (54)
Employer branding (21)
Employer resources (151)
Events (117037)
Executive appointments (957)
FDA (19426)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1429)
Gene editing (190)
Generative AI (41)
Gene therapy (576)
GLP-1 (950)
Government (4642)
Grass and pollen (6)
Guidances (381)
Healthcare (18860)
HIV (53)
Huntington's disease (43)
IgA nephropathy (81)
Immunology and inflammation (238)
Immuno-oncology (51)
Indications (96)
Infectious disease (2961)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (109)
Intellectual property (237)
Interviews (315)
IPO (16631)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (55)
Kidney cancer (15)
Labor market (82)
Layoffs (545)
Leadership (30)
Legal (7947)
Liver cancer (90)
Longevity (14)
Lung cancer (635)
Lymphoma (367)
Machine learning (42)
Management (59)
Manufacturing (763)
MASH (158)
Medical device (13737)
Medtech (13786)
Mergers & acquisitions (19937)
Metabolic disorders (1229)
Multiple sclerosis (151)
NASH (16)
Neurodegenerative disease (304)
Neuropsychiatric disorders (80)
Neuroscience (2833)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4508)
Now hiring (65)
Obesity (573)
Opinion (255)
Ovarian cancer (161)
Pain (188)
Pancreatic cancer (219)
Parkinson's disease (276)
Partnered (33)
Patents (481)
Patient recruitment (455)
Peanut (55)
People (58764)
Pharmaceutical (62)
Pharmacy benefit managers (28)
Phase I (21640)
Phase II (30545)
Phase III (22772)
Pipeline (4860)
Policy (274)
Postmarket research (2564)
Preclinical (9188)
Press Release (64)
Prostate cancer (229)
Psychedelics (44)
Radiopharmaceuticals (275)
Rare diseases (788)
Real estate (5951)
Recruiting (69)
Regulatory (24333)
Reports (51)
Research institute (2380)
Resumes & cover letters (351)
Rett syndrome (26)
RNA editing (16)
RSV (74)
Schizophrenia (144)
Series A (233)
Series B (183)
Service/supplier (11)
Sickle cell disease (94)
Special edition (21)
Spinal muscular atrophy (155)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (83)
The Weekly (52)
Vaccines (979)
Venture capital (86)
Weight loss (365)
Women's health (82)
Worklife (17)
Date
Today (21)
Last 7 days (464)
Last 30 days (2209)
Last 365 days (29766)
2026 (2243)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31482)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (13)
Asia (39154)
Australia (6398)
California (11027)
Canada (3214)
China (1064)
Colorado (464)
Connecticut (463)
Delaware (326)
Europe (84331)
Florida (1635)
Georgia (348)
Hawaii (3)
Idaho (61)
Illinois (841)
India (59)
Indiana (508)
Iowa (22)
Japan (410)
Kansas (125)
Kentucky (38)
Louisiana (25)
Maine (72)
Maryland (1363)
Massachusetts (7906)
Michigan (315)
Minnesota (617)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (120)
New Hampshire (78)
New Jersey (2943)
New Mexico (28)
New York (2906)
North Carolina (1421)
North Dakota (8)
Northern California (5361)
Ohio (326)
Oklahoma (20)
Oregon (40)
Pennsylvania (2235)
Puerto Rico (21)
Rhode Island (47)
South America (1105)
South Carolina (63)
South Dakota (1)
Southern California (4286)
Tennessee (171)
Texas (1701)
United States (39119)
Utah (328)
Vermont (1)
Virginia (255)
Washington D.C. (81)
Washington State (899)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
720,515 Results for "shouti inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ShouTi’s Rationally Designed Small Molecules are Challenging Biologics and Peptides
ShouTi believes many targets addressed by biologic and peptide therapeutics can be reached by innovative, rationally-designed, best-in-class small molecules that don’t need refrigeration or injection.
May 17, 2022
·
4 min read
·
Gail Dutton
Business
ShouTi Appoints Sharon Tetlow to Board of Directors
ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a wide range of chronic diseases, announced the appointment of Sharon Tetlow to the company’s board of directors.
March 29, 2022
·
2 min read
Drug Development
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed $33 million financing round, extending its $100 million Series B financing, which was announced in October 2021.
August 1, 2022
·
4 min read
Business
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships.
February 17, 2022
·
3 min read
Business
ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
ShouTi Inc., a clinical-stage biopharmaceutical company replacing biologics with world-class small molecule medicines using advanced computational and structure-based technology, announced that Daniel Welch has been named Chairman of the company’s board of directors.
January 20, 2022
·
3 min read
Business
ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer
ShouTi Inc., a clinical-stage biopharmaceutical company creating world-class small molecule medicines using advanced computational and structure-based technology, announced the appointment of Ding Ding, Ph.D., as Chief Financial Officer.
December 21, 2021
·
2 min read
Press Releases
Repare Announces Completion of Acquisition by XenoTherapeutics, Inc.
January 29, 2026
·
6 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Press Releases
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
January 19, 2026
·
7 min read
1 of 72,052
Next
